Recent Posts
The IGWG process offers an opportunity to fulfil the equity objectives of the Pandemic...
Co-Chairs,
Thank you for the opportunity to make a brief intervention.
Both the sharing of pathogens and the sharing of the benefits, including products and knowledge,...
WHO Members meet to finalise the Pathogen Access and Benefit Sharing Instrument
In May 2025, the WHO member states adopted the Pandemic Agreement, but they left the work to establish an instrument for Pathogen Access and...
Treatment for cystic fibrosis added to Essential Medicines List by the World Health Organization:...
The World Health Organization today announced it has added the cystic fibrosis combination treatment elexacaftor + tezacaftor + ivacaftor (brand name Trikafta) to its...
FDA approval of injectable lenacapavir for Pre-Exposure Prophylaxis (PrEP) opens the road to ending...
On 18th June 2025, the US Food and Drug Administration (FDA) approved the use of long-acting antiretroviral medicine lenacapavir (LEN-LA), for the prevention of...
Transfer of technology and know-how for the production of pandemic-related health products in the...
A version of this brief was published on 13 June '25 by the Graduate Institute as part of their 'Governing Pandemic Snapshot' series: https://www.governingpandemics.org/gp-snapshot
During...